SCHEMBL9583596

SCHEMBL9583596

CCCC=CCCC(=O)OCCCOC(OC(=O)CCC=CCCC)n1cnc2c(N)ncnc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADA P00813 4/20 0.41
▸ PDE2A O00408 3/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ PDE4A P27815 1/20 0.41
▸ PDE4B Q07343 1/20 0.41
▸ PDE4C Q08493 1/20 0.41
▸ PDE4D Q08499 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ ADORA2A P29274 1/20 0.40
▸ ADORA2B P29275 1/20 0.40
▸ ADORA1 P30542 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ BLM P54132 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10813829 0.78 ADORA2A (0.45) ADAPDE2ACYP3A4PDE4APDE4B
SCHEMBL9583606 0.74 ADORA2A (0.45) CYP3A4ALDH1A1ADORA2AADORA2BADORA1
SCHEMBL10818132 0.70 ADORA2A (0.48) ADAPDE2ACYP3A4PDE4APDE4B
SCHEMBL9582816 0.70 CDK1 (0.41) ADORA2AADORA2BADORA1
SCHEMBL10812288 0.66 CDK1 (0.40) —
SCHEMBL9583624 0.66 CYP1A2 (0.40) CYP1A2SMN1; SMN2TSHR
SCHEMBL9583138 0.66 MEN1 (0.38) ALDH1A1LMNA
SCHEMBL9583681 0.64 ADORA2A (0.55) ADAPDE2ACYP3A4PDE4APDE4B
SCHEMBL9584021 0.64 CDK5 (0.33) —
SCHEMBL8193925 0.63 ADA (0.58) ADAPDE2ACYP3A4PDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5250535-A Herpes virus; nontoxic; side effect reduction; humans and veterinary medicine SYNTEX INC. (US) 1993-10-05 — — US disclosed
US-4803271-A Process for preparing guanine derivatives SYNTEX (U.S.A.) INC. (US) 1989-02-07 — — US disclosed
US-4612314-A Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent SYNTEX (U.S.A.) INC. (US) 1986-09-16 — — US disclosed
EP-0085424-A2 Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl)purines as antiviral agent SYNTEX (U.S.A.) INC. (US) 1983-08-10 — — EP disclosed
Send feedback